← SynDRA
DAPIPRAZOLE
SynDRA canonical compound SYN0023472 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ADRA1A | ADRA1B | ADRA1D |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
| Indication | mydriasis |
|---|
| Disease area | ophthalmology |
|---|
All known targets
- ADRA1A
- ADRA1D
- ADRA1B
- ADRA2B
- Adra1a
- Adra1b
- DRD2
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- Htr1a
Mechanisms of action (all sources)
- ADRA1A ANTAGONIST
- Alpha-1a adrenergic receptor antagonist
- ADRA1D ANTAGONIST
- adrenergic receptor antagonist
- DRD2 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CHRM2
- ADRA2A
- ESR1
- DRD3
- ACHE
- MAPK3
- NPY1R
- NEIL2
- NEIL1
- MUTYH
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MBD4
- MAPK14
- NR3C1
- MAPK1
- MAOA
- LCK
- KDR
- KCNH2
- HTR6
- HRH3
- HRH2
- HRH1
- HMGCR
- NPY2R
- OPRD1
- NTHL1
- S1PR1
- TDP1
- TDG
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SMUG1
- SLC6A4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic alpha-Antagonists
- alpha-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Neurotransmitter Agents
- Psychotropic Drugs
- Tranquilizing Agents
ATC classes
- S01E · ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Cross-references
Synonyms
- DAPIPRAZOLE HYDROCHLORIDE
- dapiprazole hydrochloride
- AF-2139
- dapiprazole HCl
- Dapiprazol
- Dapiprazolum
- Dapirazol
- Dapirazolum
- Glamidolo
- Remydrial
- Reversil
- Dapiprazol [German]
- Dapiprazole [INN]
- Dapiprazole (INN)
- Dapirazol [INN-Spanish]
- Dapirazolum [INN-Latin]
- Rev-Eyes
- Rev-Eyes (TN)
- 5RNZ8GJO7K
- dapiprazolum
- CHEBI:51066
- dapiprazolo
- RefChem:57621
- DTXCID90145631
- S01EX02
- UNII-5RNZ8GJO7K
- DAPIPRAZOLE [MI]
- DAPIPRAZOLE [VANDF]
- DAPIPRAZOLE [WHO-DD]
- SCHEMBL152543
- GTPL7155
- orb1705094
- SCHEMBL29389682
- HY-A0142
- EBC-26592
- AKOS024463973
- NCGC00262927-03
- DB-055682
Look up DAPIPRAZOLE in the interactive SynDRA portal →